MM120 for Anxiety

Verified Trial

Orlando, FL

Phase 3

Recruiting

Research Sponsored by Mind Medicine, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are you willing to use contraception throughout the study period?

Be older than 18 years old

Must not have

Have you or an immediate family member (child, sibling, parent) ever been diagnosed with Schizophrenia or Bipolar Disorder?

Have you been diagnosed with PTSD?

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Summary

The reason for this study is to see if the investigational study drug, called MM120, can help people with Anxiety compared to a placebo. A placebo is an inactive drug that looks like MM120 but does not contain any active ingredients.

See full description

Eligible Conditions

Anxiety

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

Are you willing to use contraception throughout the study period?

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

Have you or an immediate family member (child, sibling, parent) ever been diagnosed with Schizophrenia or Bipolar Disorder?

Select...

Have you been diagnosed with PTSD?

Select...

Have you been diagnosed with Personality Disorder?

Select...

Have you been diagnosed with Bipolar Disorder?

Select...

Have you used psychedelics in the past 2 years? e.g. LSD, MDMA, DMT, psilocybin, ayahuasca, mescaline, mushrooms, ecstasy

Select...

Are you a daily user of marijuana? Answer NO if you are willing to stop for the 12-week duration of the study

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This study's timeline: screening for a total of 30 days, Double Blind Period for a total of 12 weeks, and an Open Label Extension for a total of 56 weeks.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

To evaluate the efficacy of a single dose of MM120 versus placebo on anxiety symptoms in adults with GAD

Secondary study objectives

To evaluate the efficacy of a single dose of MM120 versus placebo on additional measures of anxiety, functioning and quality of life in adults with GAD